Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Methods of treating multiple sclerosis, rheumatoid arthritis and inflammatory bowel disease using agonists antibodies to PILR-α

Methods of treating multiple sclerosis, rheumatoid arthritis and inflammatory bowel disease using agonists antibodies to PILR-α

US Patent 8691227 · Granted Apr 8, 2014

Estimated economic value: $55,924,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Anti-ILT4 antibodies and antigen-binding fragments2025
P116 antibodies2024
P116 antibodies2024
Anti-ILT4 antibodies and antigen-binding fragments2024
Anti-ILT4 antibodies and antigen-binding fragments2024
ILT3 ligand2022
ILT3 ligand2022
Anti-ILT4 antibodies and antigen-binding fragments2021
MDL-1 ligand2016
MDL-1 ligand2016
Use of IL-23 and IL-17 antagonists to treat autoimmune ocular inflammatory disea2013
Use of agonists and antagonists of IL-23 in the treatment of viral infection2012